<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30227689</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>03</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Print">2077-0383</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>7</Volume>                    <Issue>9</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of clinical medicine</Title>                <ISOAbbreviation>J Clin Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Association of Wnt Inhibitors, Bone Mineral Density and Lifestyle Parameters in Women with Breast Cancer Treated with Anastrozole Therapy.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">E287</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm7090287</ELocationID>            <Abstract>                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To determine the levels of Wnt inhibitors in patients treated with aromatase inhibitors (AIs) prior to therapy and to investigate their association with bone mineral density (BMD) and lifestyle parameters.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">137 breast cancer patients were divided into a group treated with 1 mg of anastrozole and a group w/o anastrozole therapy. Serum concentrations of sclerostin and dickkopf1 (DKK1) were measured by ELISA. BMD was measured by dual-energy X-ray absorptiometry (DXA). Lifestyle factors were investigated by a self-reported questionnaire.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Sclerostin was significantly higher in the AI-treated group (31.8 pmol/L vs. 24.1 pmol/L; <i>p</i> &lt; 0.001), whereas DKK1 was significantly lower in the AI-treated group (24.3 pmol/L vs. 26.02 pmol/L; <i>p</i> &lt; 0.001). Total hip and femoral neck BMD were significantly lower in the AI-treated group.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AI treatment was associated with increased levels of sclerostin and decreased levels of DKK1.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Bojanić</LastName>                    <ForeName>Kristina</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. kristina.bojanic@dzo.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Health Center Osijek, Osijek31000, Croatia. kristina.bojanic@dzo.hr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bilić Ćurčić</LastName>                    <ForeName>Ines</ForeName>                    <Initials>I</Initials>                    <Identifier Source="ORCID">0000-0002-8861-5987</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. ibcurcic@mefos.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pharmacology, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. ibcurcic@mefos.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, University Hospital Osijek, Osijek 31000, Croatia. ibcurcic@mefos.hr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kuna</LastName>                    <ForeName>Lucija</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Biology, Faculty of Dental Medicine and Health Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. lucija.kuna@fdmz.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Chemistry, Faculty of Dental Medicine and Health Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. lucija.kuna@fdmz.hr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kizivat</LastName>                    <ForeName>Tomislav</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. tomislavkizivat@gmail.com.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Clinical Institute for Nuclear Medicine and Radiation Safety, University Hospital Osijek, Osijek 31000, Croatia. tomislavkizivat@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Smolic</LastName>                    <ForeName>Robert</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. rsmolic@mefos.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pharmacology, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. rsmolic@mefos.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, University Hospital Osijek, Osijek 31000, Croatia. rsmolic@mefos.hr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Raguž Lučić</LastName>                    <ForeName>Nikola</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. nikolarlucic@gmail.com.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pharmacology, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. nikolarlucic@gmail.com.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pharmacology, Faculty of Dental Medicine and Health Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. nikolarlucic@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kralik</LastName>                    <ForeName>Kristina</ForeName>                    <Initials>K</Initials>                    <Identifier Source="ORCID">0000-0002-4481-6365</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Medical Statistics and Medical Informatics, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. kristina.kralik@mefos.hr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Šerić</LastName>                    <ForeName>Vatroslav</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. vatroslav.seric@mefos.hr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ivanac</LastName>                    <ForeName>Gordana</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Diagnostic and Interventional Radiology, University Hospital Dubrava, Zagreb 10000, Croatia. gordana.augustan@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tucak-Zorić</LastName>                    <ForeName>Sandra</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. atucak@mefos.hr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Včev</LastName>                    <ForeName>Aleksandar</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. avcev@mefos.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Medicine, University Hospital Osijek, Osijek 31000, Croatia. avcev@mefos.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pathophysiology, Faculty of Dental Medicine and Health Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. avcev@mefos.hr.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Smolić</LastName>                    <ForeName>Martina</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Mineral Metabolism, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. martina.smolic@mefos.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pharmacology, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. martina.smolic@mefos.hr.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Pharmacology, Faculty of Dental Medicine and Health Osijek, J. J. Strossmayer University of Osijek, Osijek 31000, Croatia. martina.smolic@mefos.hr.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>VIF-2017-MEFOS-5, VIF-2017-MEFOS-2</GrantID>                    <Agency>Ministry of Science and Technology, Croatia</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Switzerland</Country>            <MedlineTA>J Clin Med</MedlineTA>            <NlmUniqueID>101606588</NlmUniqueID>            <ISSNLinking>2077-0383</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Endocrinol Metab. 2015 Mar;100(3):891-901</RefSource>                <PMID Version="1">25490275</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Jan 20;28(3):509-18</RefSource>                <PMID Version="1">19949017</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Res Clin Oncol. 2014 Oct;140(10):1671-80</RefSource>                <PMID Version="1">24903965</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Carcinogenesis. 2007 Sep;28(9):1877-84</RefSource>                <PMID Version="1">17449905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Endocrinol Metab. 2010 Apr;95(4):1991-7</RefSource>                <PMID Version="1">20156921</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Osteoporos Int. 2012 Mar;23(3):1171-6</RefSource>                <PMID Version="1">21305266</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Steroids. 2011 Jul;76(8):765-7</RefSource>                <PMID Version="1">21382394</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2008 Feb 29;283(9):5866-75</RefSource>                <PMID Version="1">18089564</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Bone Miner Res. 2012 Nov;27(11):2259-63</RefSource>                <PMID Version="1">22692843</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2008 Mar 1;26(7):1051-7</RefSource>                <PMID Version="1">18309940</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocrine. 2016 Nov;54(2):543-551</RefSource>                <PMID Version="1">27601021</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Med. 2013 Feb;19(2):179-92</RefSource>                <PMID Version="1">23389618</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Osteoporos. 2014;2014:682763</RefSource>                <PMID Version="1">25548714</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Bone Miner Res. 2011 Feb;26(2):373-9</RefSource>                <PMID Version="1">20721932</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocrinol Metab (Seoul). 2015 Mar 27;30(1):58-64</RefSource>                <PMID Version="1">25827459</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Osteoporos Int. 2013 Feb;24(2):489-94</RefSource>                <PMID Version="1">22525978</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2011;6(10):e25900</RefSource>                <PMID Version="1">21991382</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Acta Reumatol Port. 2014 Apr-Jun;39(2):146-51</RefSource>                <PMID Version="1">25111416</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Autoimmun Rev. 2010 Feb;9(4):207-10</RefSource>                <PMID Version="1">19683077</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Indian J Med Paediatr Oncol. 2014 Apr;35(2):176-80</RefSource>                <PMID Version="1">25197183</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cytokine Growth Factor Rev. 2005 Jun;16(3):319-27</RefSource>                <PMID Version="1">15869900</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2008 Apr;34(2):157-74</RefSource>                <PMID Version="1">18164821</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Crit Rev Oncol Hematol. 2009 Jan;69(1):73-82</RefSource>                <PMID Version="1">18757208</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2017 Aug;164(3):737-743</RefSource>                <PMID Version="1">28526959</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Oncol Pract. 2010 Sep;6(5):243-6</RefSource>                <PMID Version="1">21197188</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2007 Oct 8;97(7):964-70</RefSource>                <PMID Version="1">17876334</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Orthop Res. 2011 Mar;29(3):414-8</RefSource>                <PMID Version="1">20939046</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Bone Miner Res. 2011 Jul;26(7):1425-36</RefSource>                <PMID Version="1">21312267</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2003 Dec 25;349(26):2483-94</RefSource>                <PMID Version="1">14695408</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Bone Miner Res. 2009 Oct;24(10):1651-61</RefSource>                <PMID Version="1">19419300</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>FASEB J. 2005 Nov;19(13):1842-4</RefSource>                <PMID Version="1">16123173</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Opin Ther Targets. 2009 Jul;13(7):839-48</RefSource>                <PMID Version="1">19530987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Behav Res Methods. 2007 May;39(2):175-91</RefSource>                <PMID Version="1">17695343</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2004 Jul 28;292(4):490-5</RefSource>                <PMID Version="1">15280347</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Densitom. 2014 Jan-Mar;17(1):66-71</RefSource>                <PMID Version="1">23562130</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Wnt signaling pathway</Keyword>            <Keyword MajorTopicYN="N">aromatase inhibitors</Keyword>            <Keyword MajorTopicYN="N">bone density</Keyword>            <Keyword MajorTopicYN="N">breast neoplasms</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>08</Month>                <Day>07</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>03</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30227689</ArticleId>            <ArticleId IdType="pii">jcm7090287</ArticleId>            <ArticleId IdType="doi">10.3390/jcm7090287</ArticleId>            <ArticleId IdType="pmc">PMC6162798</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>